BridgeBio Pharma
BBIO
BBIO
179 hedge funds and large institutions have $1.1B invested in BridgeBio Pharma in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 55 increasing their positions, 71 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
179
Holders Change
-2
Holders Change %
-1.1%
% of All Funds
2.89%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
55
Reduced
71
Closed
25
Calls
$2.08M
Puts
$761K
Net Calls
+$1.32M
Net Calls Change
+$5K
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$21.9M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$67.4M |
| 3 |
3
Barclays
London,
United Kingdom
|
$9.16M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$80.7M |
| 5 |
5
BlackRock
New York
|
$74.4M |
